Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
